Yanjun He

Jan 13, 2025 | mdpi.com | Yanjun He |Jia Shen |Xinyang Xu |Weisong Shou

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Aug 29, 2024 | onlinelibrary.wiley.com | Chuntuan Li |shengquan Liu |Jingjing Gao |Yanjun He

1 INTRODUCTION The clinical management of Mantle cell lymphoma (MCL) continues to face enduring challenges due to its incurable nature, frequent recurrence, resistance to drugs, and limited survival rates.1 Despite advancements such as novel therapies targeting CD20 and Bruton's tyrosine kinase (BTK) inhibitors, which initially showed significant clinical remission, patients eventually relapse due to chemotherapy resistance, leading to fatal outcomes.2-5 The Hh pathway has been recognized as...

Dec 24, 2023 | dx.doi.org | Jie Zeng |Lei Xie |Tianyi Liu |Yanjun He

RETURN TO ARTICLES ASAPPREVFunctional Inorganic...Functional Inorganic Materials and DevicesNEXTJie ZengShanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai 201318, ChinaDepartment of Chemistry, Shanghai Key Lab of Molecular Catalysis and Innovative Materials, Collaborative Innovation Center of Chemistry for Energy Materials, Fudan University, Shanghai 200438, P. R.